Clinical Trial Update: Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)

View source ↗

Summary

This clinical trial update discusses the potential pathophysiological role of incretin hormones in maturity-onset diabetes of the young (MODY) based on the comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maturity-onset Diabetes of the Young

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Maturity-onset Diabetes of the Young | Status: COMPLETED